Kintor Ties Up With Chicmax to Commercialize KT-939 Whitening Ingredient and Fund Core Drug Pipeline

Kintor Pharmaceutical Ltd ( (HK:9939) ) has shared an update.

Kintor Pharmaceutical’s subsidiary Suzhou Kintor has signed an exclusive strategic cooperation framework agreement with Shanghai Chicmax Cosmetic to rapidly commercialize KT-939, a whitening and freckle-removing functional cosmetic raw material positioned as a leading domestic whitening agent. Under the deal, the partners will jointly register KT-939 as a new cosmetic ingredient, develop and register products using it as the main active, and collaborate on customized functional raw materials while sharing technology and market resources.

Kintor plans to use cash flow generated from KT-939’s functional cosmetic raw materials business to support development and commercialization of its core drug candidates KX-826, GT20029 and other pipeline assets, keeping aligned with its existing listed biopharmaceutical business. By combining Chicmax’s strong brand operations, R&D and extensive distribution network with Suzhou Kintor’s raw material research expertise, the cooperation is expected to accelerate time-to-market, enhance the technological level and competitiveness of domestic whitening ingredients, and strengthen both companies’ positions in China’s cosmetics and biopharma-adjacent markets.

The most recent analyst rating on (HK:9939) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on Kintor Pharmaceutical Ltd stock, see the HK:9939 Stock Forecast page.

More about Kintor Pharmaceutical Ltd

Kintor Pharmaceutical Limited is a biopharmaceutical company focused on innovative drug research and development, with core products including KX-826 and GT20029 and a broader pipeline targeting dermatology and related indications. Through its wholly owned subsidiary Suzhou Kintor, the group is also developing functional cosmetic raw materials such as KT-939, aiming to tap China’s fast-growing cosmetics and dermocosmetics markets and diversify its revenue base.

Average Trading Volume: 3,221,847

Technical Sentiment Signal: Buy

Current Market Cap: HK$2.27B

See more data about 9939 stock on TipRanks’ Stock Analysis page.